Management of Lenoir's Sign (Épine de Lenoir)
Lenoir's sign, a clinical indicator of cervical myelopathy, requires prompt neurological evaluation and appropriate imaging to determine the underlying cause and prevent progression of neurological damage.
Clinical Presentation and Significance
- Lenoir's sign (épine de Lenoir) is characterized by an electric shock-like sensation that travels down the spine, arms, and sometimes legs when the neck is flexed, similar to Lhermitte's sign 1, 2
- This sign is an important clinical indicator of cervical spinal cord pathology and should prompt immediate evaluation to prevent progression of neurological damage 3
- The sign is caused by stretching of demyelinated fibers in the posterior columns of the cervical spinal cord during neck movement 1
Diagnostic Approach
Initial Assessment
- Perform a thorough neurological examination focusing on upper motor neuron signs including hyperreflexia, Babinski sign, Tromner sign, and clonus, which are highly specific for cervical myelopathy 4
- Assess for other neurological symptoms including weakness, sensory changes, gait abnormalities, and bladder/bowel dysfunction 3
- Document any history of trauma, which may suggest post-traumatic spinal cord injury without radiographic abnormality (SCIWORA) 5
Imaging Studies
- MRI of the brain and cervical spine is the first-line imaging modality with highest diagnostic yield for identifying the underlying cause 6
- MRI should be performed within 24 hours if symptoms are severe or progressive 6
- If MRI is unavailable, urgent CT of the cervical spine should be performed, followed by MRI when available 6
- Look for key MRI findings including:
Management Based on Etiology
Degenerative Cervical Myelopathy
For mild symptoms without significant cord compression:
For moderate to severe symptoms or evidence of significant cord compression:
Multiple Sclerosis or Other Demyelinating Conditions
- Refer to neurology for comprehensive evaluation 3
- High-dose corticosteroids may be indicated for acute demyelinating episodes 3
- Disease-modifying therapies should be initiated if multiple sclerosis is diagnosed 2
Vitamin B12 Deficiency (Subacute Combined Degeneration)
- Check serum vitamin B12 levels, methylmalonic acid, and homocysteine 1
- Initiate vitamin B12 supplementation (typically intramuscular injections initially) 1
- Symptoms typically improve with appropriate B12 replacement therapy 1
Post-Traumatic (SCIWORA)
- Immediate spinal immobilization with a rigid cervical collar 5
- Consider high-dose steroid therapy according to spinal cord injury protocols 5
- Avoid activities that could exacerbate injury 5
- Surgical intervention may be necessary if there is evidence of instability or persistent compression 5
Camptocormia (Bent Spine Syndrome)
- If Lenoir's sign is associated with abnormal trunk flexion, consider evaluation for camptocormia 7
- Determine if primary (axial myopathy) or secondary to neurological disorders like Parkinson's disease 7
- Management includes physical therapy, walking aids, and treatment of underlying cause 7
Follow-up and Monitoring
- Schedule follow-up within 2-4 weeks to assess response to treatment and symptom progression 3
- Repeat imaging may be necessary if symptoms worsen or fail to improve with conservative management 3
- Consider referral to specialized centers for complex cases or those requiring surgical intervention 3
Precautions and Patient Education
- Advise patients to avoid activities that trigger the symptom, particularly extreme neck flexion 2
- Educate patients about warning signs that should prompt immediate medical attention (progressive weakness, numbness, bowel/bladder dysfunction) 3
- Provide appropriate pain management while addressing the underlying cause 3
Special Considerations
- In elderly patients or those with vascular risk factors, consider vascular causes of myelopathy 3
- In patients with professional voice requirements, be aware that cervical pathology can sometimes affect laryngeal function 3
- For patients with concurrent visual symptoms, consider expanded neurological evaluation including ophthalmological assessment 3